Post
Cybin completes dosing final cohort in MDD therapy trial
Cybin has completed dosing the final cohort in a Phase II study of CYB003 to treat moderate to severe major …
Aclaris finishes enrolment in atopic dermatitis Phase IIb trial of ATI-1777
Aclaris Therapeutics has concluded the enrolment of 250 patients in the Phase IIb ATI-1777-AD-202 study of ATI-1777 to treat mild …
Roche’s Evrysdi meets primary endpoint in trial for babies with SMA
Roche presented positive results from the Phase II Rainbowfish trial of Evrysdi (risdiplam) at the 28th World Muscle Society (WMS) …
Medable and Pluto Health partner to optimise clinical trials
Technology provider Medable has joined forces with Pluto Health, a care coordination services company, to improve and optimise access to …
Disc Medicine commences trial of DISC-3405 monoclonal antibody
Disc Medicine has commenced a Phase I study of the DISC-3405 monoclonal antibody in healthy volunteers. The single and multiple-ascending dose, …
Loci Orthopaedics kicks off study of artificial thumb joints
An Ireland-based orthopaedics firm has announced that they have concluded enrollment for a feasibility study surrounding the surgical implantation of …
Aclaris finishes enrolment in atopic dermatitis Phase IIb trial of ATI-1777
Aclaris Therapeutics has concluded the enrolment of 250 patients in the Phase IIb ATI-1777-AD-202 study of ATI-1777 to treat mild …
Roche’s Evrysdi meets primary endpoint in trial for babies with SMA
Roche presented positive results from the Phase II Rainbowfish trial of Evrysdi (risdiplam) at the 28th World Muscle Society (WMS) …
Medable and Pluto Health partner to optimise clinical trials
Technology provider Medable has joined forces with Pluto Health, a care coordination services company, to improve and optimise access to …
Disc Medicine commences trial of DISC-3405 monoclonal antibody
Disc Medicine has commenced a Phase I study of the DISC-3405 monoclonal antibody in healthy volunteers. The single and multiple-ascending dose, …
Lokavant receives funding to bring trial intelligence platform into APAC
Lokavant has secured funding of $8m in a Series A extension round from global investment company Mitsui for expanding its AI clinical trial …
Ubiquigent joins Imperial College London for DUB probe discovery
Ubiquigent has announced that they will support a PhD student in the Institute of Chemical Biology EPSRC Centre for Doctoral …
ALX Oncology’s gastric cancer drug shows positive interim results from its ASPEN-06 clinical trial
ALX Oncology has announced positive interim results with evorpacept in a study to treat advanced HER2-positive gastric cancer as part …
Kineta’s solid tumour candidate clears first three monotherapy cohorts
Kineta has reported positive safety and biomarker data for its immuno-oncology candidate KVA12123 in a Phase I/II trial. The VISTA-101 trial …
Serialization readiness: the path towards compliance
The Food Drug Administration (FDA) recently introduced a 12-month stabilization period, from November 2023 to November 2024, for the pharmaceutical …